40-F/A

AMENDMENT NO. 1 TO FORM 40-F

Company: Aurinia Pharmaceuticals Inc.
Filed: May 15, 2015
Period of Report: December 31, 2014
Accession Number: 0001193125-15-190455

View Document ↗ View on SEC.gov ↗